Abstract:Background High-level expression of NAD(P)H: quinoneoxidoreductase 1 (NQO1) has been correlated with many types of human cancers, suggesting that NQO1 plays important roles in tumor occurrence and progression. This study attempted to explore the role of NQO1 in tumor progression and prognostic evaluation of non-small cell lung cancer (NSCLC). Methods Total 164 tissue samples, including 150 NSCLC paired with the adjacent non-tumor tissues and 14 normal lung tissues, were picked-up for immunohistochemical (IHC) staining of the NQO1 protein, and immunofluorescence (IF) staining was also performed to detect the subcellular localization of the NQO1 protein in A549 human lung cancer cells. The correlation between NQO1 expression and clinicopathological characteristics were evaluated by Chi-square test and Fisher’s exact tests. The disease-free survival (DFS) and overall survival (OS) rates of NSCLC patients were calculated by the Kaplan-Meier method, and univariate and multivariate analyses were performed using the Cox proportional hazards regression model. Results The NQO1 protein showed a mainly cytoplasmic staining pattern in lung cancer cells, including adenocarcinoma and squamous cell carcinoma (SCC). Both positive rate and strongly positive rate of NQO1 protein expression were significantly higher in NSCLC (59.3% and 28.0%) than that in adjacent non tumor (8.0% and 1.3%) and normal lung tissues (0%). The positive rate of NQO1 was related with clinical stage and lymph node metastasis, and the strongly positive rate of NQO1 protein was significantly correlated with tumor size, poor differentiation, advanced clinical stage and lymph node metastasis in NSCLC. Additionally, survival analyses showed that the patients with NQO1 positive expression had lower OS rates compared with those with NQO1 negative expression in the groups of T1-2, T3-4, without LN metastasis and stage I-II of NSCLC, respectively; however, in the groups of patients with LN metastasis or III-IV stages, OS rate was not correlated with NQO1 expression status. Moreover, multivariate analysis suggested that NQO1 emerged as a significant independent prognostic factor along with tumor size, differentiation, lymph node metastasis and clinical stage in patients with NSCLC. Conclusions NQO1 is upregulated in NSCLC, and it may be a useful poor prognostic biomarker and a potential therapeutic target for patients with NSCLC.

Loss of Beclin1 expression and Nrf2 overexpression are associated with poor survival of patients with non-small cell lung cancer.

Beclin 1 and P62 Expression in Non-Small Cell Lung Cancer: Relation with Malignant Behaviors and Clinical Outcome.

Reduced Expression of Liver Kinase B1 and Beclin1 is Associated with the Poor Survival of Patients with Non-Small Cell Lung Cancer

Nrf2 Promotes Progression of Non-Small Cell Lung Cancer Through Activating Autophagy

Autophagic Protein Beclin 1 Serves As an Independent Positive Prognostic Biomarker for Non-Small Cell Lung Cancer.

ERCC1, RRM1 and BRCA1 Mrna Expression Levels and Clinical Outcome of Advanced Non-Small Cell Lung Cancer.

Expression of Beclin-1 in non-small cell lung cancer and its clinical significance

NRF2-regulated metabolic gene signature as a prognostic biomarker in non-small cell lung cancer.

Expression of ATM , CHK 2 and BRCA 1 predicts the clinical outcome of non-small cell lung cancer in patients receiving platinum-based chemotherapy

Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis

Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis

Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy

Low expression of Beclin 1 and elevated expression of HIF-1α refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer

Beclin 1 Deficiency Correlated with Lymph Node Metastasis, Predicts a Distinct Outcome in Intrahepatic and Extrahepatic Cholangiocarcinoma.

Nad(P)H:Quinone Oxidoreductase-1 Overexpression Predicts Poor Prognosis in Small Cell Lung Cancer

Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer

Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma.

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers

High NF-E2-related Factor 2 Expression Predicts Poor Prognosis in Patients with Lung Cancer: a Meta-Analysis of Cohort Studies.

Expression of Beclin 1 in Bladder Cancer and Its Clinical Significance

Correlation of the expression of T lymphocyte subsets and NK cells to clinical stage and prognosis in patients with non-small cell lung cancer